Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Helius Medical Technologies Inc HSDT

Helius Medical Technologies, Inc. is a neurotech company in the medical device field. It is focused on neurologic deficits using orally applied technology platform that amplifies the brain’s ability to engage physiologic compensatory mechanisms enhancing the lives of people dealing with neurologic diseases. It develops, licenses, or acquires non-implantable technologies targeted at reducing symptoms of neurological disease or trauma. Its product Portable Neuromodulation Stimulator (PoNS) is a non-implantable medical device, inclusive of a controller and mouthpiece, which delivers mild electrical stimulation to the surface of the tongue to provide treatment of gait deficit and chronic balance deficit. PoNS Therapy is integral to the overall PoNS solution and is the physical therapy applied by patients during use of the PoNS neuromodulation stimulator. PoNS is used as an adjunct to a supervised therapeutic exercise program in patients 22 years of age and over by prescription only.


NDAQ:HSDT - Post by User

Post by prokofievon Jan 24, 2018 8:41am
200 Views
Post# 27422384

Helius & US Army Launch Additional PoNS® Research

Helius & US Army Launch Additional PoNS® ResearchHelius is such a crappy company and has such a shitty product that the US Army decided to launch a new research program to investigate PoNS for the enhancement of cognitive, emotional and physical readiness and response through mindfulness and meditation training.

Prokofiev



Helius Medical Technologies and US Army Research Laboratory Launch Additional PoNS® Research

NEWTOWN, Pa., Jan. 24, 2018 (GLOBE NEWSWIRE) -- 

Helius Medical Technologies, Inc. (TSX:HSM) (TSX:HSM.WT) (OTCQB:HSDT) (“Helius” or the “Company”), a medical technology company focused on neurological wellness, announced that together with the US Army Research Laboratory (ARL), it has executed a Cooperative Research and Development Agreement (CRADA) establishing a platform for collaborative research programs. Subsequently, Helius and ARL executed a Joint Work Statement (JWS) launching a research program to investigate Helius’ Portable Neuromodulation Stimulator (PoNS) for the enhancement of cognitive, emotional and physical readiness and response through mindfulness and meditation training.

The US Army Research Laboratory conducts a broad program of fundamental research within its Human Sciences S&T Campaign. A major emphasis of the program is identifying and advancing novel techniques and technologies that can improve cognitive, emotional and physical performance to provide new capabilities for maximizing soldier readiness and response.

Currently, ARL is studying the use of mindfulness-based stress reduction (MBSR) among soldiers and veterans. ARL researchers have found that individuals who complete MBSR training often achieve results that can positively affect a soldier’s readiness, attention, energy, and vigor as well as decrease stress, symptoms of PTSD, and sleepiness - a top priority of General Mark A. Milley, Chief of Staff of the Army.

Dr. Jonathan Sackier, Chief Medical Officer at Helius commented, "We are delighted to be collaborating with Dr. Valerie Rice and the team at the Army Research Laboratory and are looking forward to launching the collaborative investigation into whether the PoNS can augment the effects of MBSR training. Addressing issues such as post-traumatic stress and sleep disorders is a major problem not only in the military, but the civilian population in the wake of terrorist attacks, natural and other disasters."

"Partnerships with companies like Helius Medical Technologies are exactly the kind of exciting opportunities that we have envisioned with ARL's Open Campus initiative," added Kelvin S. Oie, ARL's Senior Campaign Scientist for the Human Sciences. "Open Campus relationships allow us to work together with innovative researchers and developers, both in industry and academia, to rapidly advance new capabilities that will help our soldiers, today and tomorrow.”

Bullboard Posts